Consonance Capital Management’s CORINDUS VASCULAR ROBOTICS, INC CVRS Stock Holding History

Consonance Capital Management’s Portfolio CVRS Stock Details CVRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-4,574,835	Closed	-$6.27M	–	33
2018 Q1	$6.27M	Sell	4,574,835 -1,411,170	-24%	-$1.64M	0.57%	25
2017 Q4	$6.05M	Sell	5,986,005 -5,877,348	-50%	-$6.65M	0.55%	21
2017 Q3	$18M	Sell	11,863,353 -3,251,519	-22%	-$5.45M	1.99%	14
2017 Q2	$28.1M	Hold	15,114,872	–	–	3.31%	12
2017 Q1	$19.8M	Buy	+15,114,872	New	+$12.3M	2.08%	15

Other funds holding CVRS

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

HEC

Hudson Executive Capital New York $50.9M AUM 22.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return

PVAM

Pacific View Asset Management San Francisco, California $20.8M AUM 20.08% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Consonance Capital Management's CVRS Position: Q2 2018 in Review

Consonance Capital Management sold out of CORINDUS VASCULAR ROBOTICS, INC (CVRS) in Q2 2018, closing a stake of 4,574,835 shares — an estimated $6.27M sold.

Consonance Capital Management first reported a position in CVRS in Q1 2017 and held it in 5 quarters. The position peaked at $28.1M in Q2 2017. 53 funds tracked by Wall St. Rank hold CVRS as of Q2 2018.

Consonance Capital Management reported no remaining CORINDUS VASCULAR ROBOTICS, INC position as of Q2 2018 after selling out during the quarter.
Consonance Capital Management sold 4,574,835 CORINDUS VASCULAR ROBOTICS, INC shares in Q2 2018, an estimated $6.27M.
Consonance Capital Management first reported a position in CORINDUS VASCULAR ROBOTICS, INC in Q1 2017 and held it in 5 quarters.
Consonance Capital Management's CORINDUS VASCULAR ROBOTICS, INC position peaked at $28.1M in Q2 2017.
53 funds tracked by Wall St. Rank held CORINDUS VASCULAR ROBOTICS, INC as of Q2 2018.

Based on Consonance Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.